Tsunehiro Matsubara

619 total citations
13 papers, 379 citations indexed

About

Tsunehiro Matsubara is a scholar working on Epidemiology, Infectious Diseases and Rheumatology. According to data from OpenAlex, Tsunehiro Matsubara has authored 13 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Rheumatology. Recurrent topics in Tsunehiro Matsubara's work include Sepsis Diagnosis and Treatment (5 papers), GDF15 and Related Biomarkers (3 papers) and COVID-19 Clinical Research Studies (2 papers). Tsunehiro Matsubara is often cited by papers focused on Sepsis Diagnosis and Treatment (5 papers), GDF15 and Related Biomarkers (3 papers) and COVID-19 Clinical Research Studies (2 papers). Tsunehiro Matsubara collaborates with scholars based in Japan. Tsunehiro Matsubara's co-authors include Hiroshi Ogura, Hiroshi Matsuura, Hisatake Matsumoto, Kentaro Shimizu, Sujin Kang, Toshio Tanaka, Shoji Hashimoto, Yoshiyuki Kioi, Tadamitsu Kishimoto and Yoshiharu Matsuura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and Thrombosis Research.

In The Last Decade

Tsunehiro Matsubara

11 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tsunehiro Matsubara Japan 8 134 107 82 81 65 13 379
Chiara Barbieri Italy 10 126 0.9× 83 0.8× 75 0.9× 57 0.7× 74 1.1× 15 443
Christophe Nougier France 11 203 1.5× 52 0.5× 88 1.1× 42 0.5× 88 1.4× 44 560
Ivette Buendía-Roldán Mexico 12 131 1.0× 66 0.6× 105 1.3× 76 0.9× 58 0.9× 52 372
Chuen Wen Tan Singapore 9 139 1.0× 32 0.3× 66 0.8× 19 0.2× 101 1.6× 31 366
Sebastian Koball Germany 10 47 0.4× 56 0.5× 42 0.5× 43 0.5× 48 0.7× 30 329
Suqin Ben China 11 41 0.3× 79 0.7× 67 0.8× 49 0.6× 25 0.4× 21 451
Badder Kattih Germany 8 162 1.2× 38 0.4× 184 2.2× 31 0.4× 89 1.4× 14 467
Anis John Kadado United States 8 109 0.8× 42 0.4× 39 0.5× 25 0.3× 49 0.8× 22 411
Ying Feng China 12 42 0.3× 55 0.5× 81 1.0× 21 0.3× 38 0.6× 30 380
Mototsugu Nishii Japan 15 51 0.4× 86 0.8× 86 1.0× 57 0.7× 20 0.3× 30 581

Countries citing papers authored by Tsunehiro Matsubara

Since Specialization
Citations

This map shows the geographic impact of Tsunehiro Matsubara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsunehiro Matsubara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsunehiro Matsubara more than expected).

Fields of papers citing papers by Tsunehiro Matsubara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsunehiro Matsubara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsunehiro Matsubara. The network helps show where Tsunehiro Matsubara may publish in the future.

Co-authorship network of co-authors of Tsunehiro Matsubara

This figure shows the co-authorship network connecting the top 25 collaborators of Tsunehiro Matsubara. A scholar is included among the top collaborators of Tsunehiro Matsubara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsunehiro Matsubara. Tsunehiro Matsubara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Oda, Sayaka, Hisatake Matsumoto, Tsunehiro Matsubara, et al.. (2025). Changes in gene expression in healthcare workers during night shifts: implications for immune response and health risks. Journal of Intensive Care. 13(1). 14–14.
2.
Matsumoto, Hisatake, et al.. (2024). Plasma proteomics profile-based comparison of torso versus brain injury: A prospective cohort study. The Journal of Trauma: Injury, Infection, and Critical Care. 97(4). 557–565.
3.
Matsumoto, Hisatake, Jumpei Yoshimura, Tsunehiro Matsubara, et al.. (2022). Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients. Molecular Therapy — Nucleic Acids. 29. 343–353. 13 indexed citations
4.
Ebihara, Takeshi, Tsunehiro Matsubara, Hisatake Matsumoto, et al.. (2022). Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients. Journal of Clinical Immunology. 43(2). 286–298. 10 indexed citations
5.
Ebihara, Takeshi, Hisatake Matsumoto, Tsunehiro Matsubara, et al.. (2022). Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19. Frontiers in Immunology. 13. 830061–830061. 19 indexed citations
6.
Ebihara, Takeshi, Hisatake Matsumoto, Tsunehiro Matsubara, et al.. (2022). Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis. Frontiers in Immunology. 12. 798338–798338. 24 indexed citations
7.
Onishi, Shinya, Takeshi Ebihara, Tsunehiro Matsubara, et al.. (2022). Growth Differentiation Factor-15 Correlates with Mortality and Severity in Severe Burns. Shock. 57(6). 211–217. 1 indexed citations
8.
Matsuura, Hiroshi, Hisatake Matsumoto, Daisuke Okuzaki, et al.. (2021). Hydrogen Gas Therapy Attenuates Inflammatory Pathway Signaling in Septic Mice. Journal of Surgical Research. 263. 63–70. 7 indexed citations
9.
Ebihara, Takeshi, Hisatake Matsumoto, Tsunehiro Matsubara, et al.. (2021). Adipocytokine Profile Reveals Resistin Forming a Prognostic-Related Cytokine Network in the Acute Phase of Sepsis. Shock. 56(5). 718–726. 17 indexed citations
10.
Kang, Sujin, Toshio Tanaka, Hitomi Inoue, et al.. (2020). IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proceedings of the National Academy of Sciences. 117(36). 22351–22356. 234 indexed citations
11.
Matsubara, Tsunehiro, Yutaka Umemura, Hiroshi Ogura, et al.. (2020). Bone Marrow-Derived Mononuclear Cell Transplantation Can Reduce Systemic Inflammation and Endothelial Glycocalyx Damage in Sepsis. Shock. 56(2). 260–267. 4 indexed citations
12.
13.
Matsubara, Tsunehiro, Kazuma Yamakawa, Yutaka Umemura, et al.. (2019). Significance of plasma fibrinogen level and antithrombin activity in sepsis: A multicenter cohort study using a cubic spline model. Thrombosis Research. 181. 17–23. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiara Barbieri Breakdown of academic impact, for papers by Christophe Nougier Breakdown of academic impact, for papers by Ivette Buendía-Roldán Breakdown of academic impact, for papers by Chuen Wen Tan Breakdown of academic impact, for papers by Sebastian Koball Breakdown of academic impact, for papers by Suqin Ben Breakdown of academic impact, for papers by Badder Kattih Breakdown of academic impact, for papers by Anis John Kadado Breakdown of academic impact, for papers by Ying Feng Breakdown of academic impact, for papers by Mototsugu Nishii
Rankless by CCL
2026